The SNARE proteins syntaxin and SNAP-25, both anchored in the presynaptic membrane, and VAMP (also called synaptobrevin), which is anchored in the synaptic vesicle membrane, form a tight ternary complex that drives membrane fusion and hence neurotransmitter release. We previously showed that a mutation in C. elegans syntaxin,
unc-64(
md130) , dominantly blocks the effect of the volatile anesthetics (VA) isoflurane and halothane at clinical concentrations. We believe this and other results are most consistent with the
md130 product blocking the binding or transduction of binding of VAs to a syntaxin interacting protein. To ask directly whether one of the SNARE proteins might be a VA target, we produced recombinant C. elegans and rat SNARE proteins and measured their ability to bind isoflurane by 19 F- NMR spectroscopy. C. elegans and rat syntaxin, SNAP-25 and VAMP, each His 6 -tagged and lacking its C-terminal transmembrane domain (syntaxin and VAMP) or its palmitoylation (SNAP-25), were cloned into vectors (pHO2c or pHO4d), expressed in BL21(DE3) bacteria, and purified by Ni-NTA agarose chromatography. Isoflurane binding to the recombinant proteins was measured by 19 F-NMR spin-spin-relaxation (T2). Resulting T2 times are indicative of binding when significantly lower than buffer. The recombinant SNARE proteins had distinctively different isoflurane binding characteristics. Rat SNAP-25 clearly lowered the isoflurane T2 in what appeared to be a dose-dependent manner at clinical concentrations of isoflurane (0.1 - 0.6 mM). In contrast, rat syntaxin binds isoflurane in a non-dose-dependent manner with a very low T2 time, not saturating over a 100-fold range of isoflurane concentrations (0.06 - 6.0 mM). This is suggestive of many low-affinity non-specific binding sites. Rat VAMP and the C. elegans orthologs of SNAP-25, syntaxin, and VAMP produced T2 values comparable to buffer alone therefore not binding to isoflurane. However, unlike r-SNAP-25, our recombinant ce-SNAP-25 does not appear to be capable of forming a ternary complex with syntaxin/VAMP and may not have a tertiary structure resembling that in vivo. In conclusion, SNAP-25 is the first neuronal protein shown to bind VAs and may be a relevant VA target mediating general anesthesia in vivo.